4//SEC Filing
Lane Michael 4
Accession 0000874716-25-000026
CIK 0000874716other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:43 PM ET
Size
26.6 KB
Accession
0000874716-25-000026
Insider Transaction Report
Form 4
Lane Michael
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2025-02-14+160→ 6,650.235 total - Exercise/Conversion
Common Stock
2025-02-14+204→ 6,854.235 total - Exercise/Conversion
Common Stock
2025-02-14+220→ 7,074.235 total - Exercise/Conversion
Common Stock
2025-02-14+301→ 7,375.235 total - Tax Payment
Common Stock
2025-02-14$444.53/sh−272$120,912→ 7,103.235 total - Award
Non-Qualified Stock Option (right-to-buy)
2025-02-13+6,320→ 6,320 totalExercise: $459.76Exp: 2035-02-12→ Common Stock (6,320 underlying) - Award
Incentive Stock Option (right-to-buy)
2025-02-13+217→ 217 totalExercise: $459.76Exp: 2035-02-12→ Common Stock (217 underlying) - Award
Restricted Stock Unit
2025-02-13+1,468→ 1,468 total→ Common Stock (1,468 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-14−160→ 0 total→ Common Stock (160 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-14−204→ 204 total→ Common Stock (204 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-14−220→ 440 total→ Common Stock (220 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-14−301→ 903 total→ Common Stock (301 underlying)
Holdings
- 592(indirect: By Spouse)
Common Stock
Footnotes (9)
- [F1]Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 30, 2024 and December 31, 2024.
- [F2]Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
- [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
- [F4]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
- [F5]Grant of restricted stock units ('RSU') that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.
- [F6]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2022.
- [F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023.
- [F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
- [F9]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001740689
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 9:43 PM ET
- Size
- 26.6 KB